N-Cyclobutyl-N-(4-ethylphenyl)-4-hydroxy-2-(tetrahydro-2H-pyran-4-yl)chromane-6-sulfonamide

ID: ALA5285102

Chembl Id: CHEMBL5285102

Max Phase: Preclinical

Molecular Formula: C26H33NO5S

Molecular Weight: 471.62

Associated Items:

Names and Identifiers

Canonical SMILES:  CCc1ccc(N(C2CCC2)S(=O)(=O)c2ccc3c(c2)C(O)CC(C2CCOCC2)O3)cc1

Standard InChI:  InChI=1S/C26H33NO5S/c1-2-18-6-8-21(9-7-18)27(20-4-3-5-20)33(29,30)22-10-11-25-23(16-22)24(28)17-26(32-25)19-12-14-31-15-13-19/h6-11,16,19-20,24,26,28H,2-5,12-15,17H2,1H3

Standard InChI Key:  NIQAXHRTVPHVOC-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5285102

    ---

Associated Targets(Human)

RORC Tchem Nuclear receptor ROR-gamma (8495 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RORA Tchem Nuclear receptor ROR-alpha (562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RORB Tchem Nuclear receptor ROR-beta (600 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 471.62Molecular Weight (Monoisotopic): 471.2079AlogP: 4.61#Rotatable Bonds: 6
Polar Surface Area: 76.07Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.90CX Basic pKa: CX LogP: 4.06CX LogD: 4.06
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.67Np Likeness Score: -0.08

References

1. Chen L, Su M, Jin Q, Wang W, Wang CG, Assani I, Wang MX, Zhao SF, Lv SM, Wang JW, Sun B, Li Y, Liao ZX..  (2021)  Discovery of Chromane-6-Sulfonamide Derivative as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist.,  64  (21.0): [PMID:34723528] [10.1021/acs.jmedchem.1c01436]

Source